Congressional watchdog advises HHS to implement 'post-marketing' incentives to address dwindling antibiotic development efforts
With the Covid-19 crisis expected to shore up antibiotic use with opportunistic secondary bacterial infections — and potentially exacerbate the rate antibiotic resistance — a congressional …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
